These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2126692)

  • 21. Emergence of highly trimethoprim-sulfamethoxazole-resistant Shigella in a native American population: an epidemiologic study.
    Griffin PM; Tauxe RV; Redd SC; Puhr ND; Hargrett-Bean N; Blake PA
    Am J Epidemiol; 1989 May; 129(5):1042-51. PubMed ID: 2650535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of activity of sulfamethoxazole and trimethoprim against anaerobic bacteria.
    Rosenblatt JE; Stewart PR
    Antimicrob Agents Chemother; 1974 Jul; 6(1):93-7. PubMed ID: 15828176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous peritonitis caused by Enterococcus faecium.
    Pascual J; Sureda A; Lopez-San Roman A; Barcena R; De Rafael L; Hernandez-Cabrero J; Boixeda D
    J Clin Microbiol; 1990 Jun; 28(6):1484-6. PubMed ID: 2380371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of bovine lactoferrin on the minimum inhibitory concentrations of ampicillin and trimethoprim-sulfamethoxazole for clinical Shigella spp. strains.
    Mosquito S; Zegarra G; Villanueva C; Ruiz J; Ochoa TJ
    Biochem Cell Biol; 2012 Jun; 90(3):412-6. PubMed ID: 22397495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of trimethoprim and sulfamethoxazole (TMP-SMX) in dermatology.
    Michałek K; Lechowicz M; Pastuszczak M; Wojas-Pelc A
    Folia Med Cracov; 2015; 55(1):35-41. PubMed ID: 26774630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim-sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection.
    Gomolin IH; Siami PF; Reuning-Scherer J; Haverstock DC; Heyd A;
    J Am Geriatr Soc; 2001 Dec; 49(12):1606-13. PubMed ID: 11843992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trial.
    Klein NC; Duncanson FP; Lenox TH; Forszpaniak C; Sherer CB; Quentzel H; Nunez M; Suarez M; Kawwaff O; Pitta-Alvarez A
    AIDS; 1992 Mar; 6(3):301-5. PubMed ID: 1567574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of CAPD peritonitis with oral trimethoprim/sulfamethoxazole and intraperitoneal aminoglycoside combination.
    Celik A; Cirit M; Tünger A; Akçiçek F; Basçi A
    Perit Dial Int; 1999; 19(3):284-5. PubMed ID: 10433171
    [No Abstract]   [Full Text] [Related]  

  • 29. Trimethoprim-sulfamethoxazole therapy of experimental Escherichia coli meningitis in rabbits.
    Mylotte JM; Bates TR; Sergeant KA; Matson RE; Beam TR
    Antimicrob Agents Chemother; 1981 Jul; 20(1):81-7. PubMed ID: 7025751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis (CAPD).
    Walker SE; Paton TW; Churchill DN; Ojo B; Manuel MA; Wright N
    Perit Dial Int; 1989; 9(1):51-5. PubMed ID: 2488182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic treatment of acute shigellosis: failure of cefamandole compared with trimethoprim/ sulfamethoxazole and ampicillin.
    Orenstein WA; Ross L; Overturf GD; Wilkins J; Redfield DR; Underman A
    Am J Med Sci; 1981; 282(1):27-33. PubMed ID: 7270569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trimethoprim-sulfamethoxazole activity and pharmacodynamics against glycopeptide-intermediate Staphylococcus aureus.
    Close SJ; McBurney CR; Garvin CG; Chen DC; Martin SJ
    Pharmacotherapy; 2002 Aug; 22(8):983-9. PubMed ID: 12173801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissemination of Trimethoprim-Sulfamethoxazole Drug Resistance Genes Associated with Class 1 and Class 2 Integrons Among Gram-Negative Bacteria from HIV Patients in South India.
    Ramesh Kumar MR; Arunagirinathan N; Srivani S; Dhanasezhian A; Vijaykanth N; Manikandan N; Balakrishnan S; Vignesh R; Balakrishnan P; Solomon S; Solomon SS
    Microb Drug Resist; 2017 Jul; 23(5):602-608. PubMed ID: 27854149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized clinical trial of rifampin-trimethoprim and sulfamethoxazole-trimethoprim in the treatment of localized urinary tract infections.
    Stein GE; Gurwith D; Gurwith M
    Antimicrob Agents Chemother; 1988 Jun; 32(6):802-6. PubMed ID: 3046481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ampicillin therapy of experimental enterococcal endocarditis.
    Tight RR
    Antimicrob Agents Chemother; 1980 Aug; 18(2):307-10. PubMed ID: 7447407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges.
    Dudley MN; Levitz RE; Quintiliani R; Hickingbotham JM; Nightingale CH
    Antimicrob Agents Chemother; 1984 Dec; 26(6):811-4. PubMed ID: 6335381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of sulfamethoxazole--trimethoprim combination during chronic peritoneal dialysis: effect of peritonitis.
    Singlas E; Colin JN; Rottembourg J; Meessen JP; de Martin A; Legrain M; Simon P
    Eur J Clin Pharmacol; 1982; 21(5):409-15. PubMed ID: 7075646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: increasing frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid.
    Bennish ML; Salam MA; Hossain MA; Myaux J; Khan EH; Chakraborty J; Henry F; Ronsmans C
    Clin Infect Dis; 1992 May; 14(5):1055-60. PubMed ID: 1600006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of the concomitant use of methotrexate and a prophylactic dose of trimethoprim-sulfamethoxazole.
    Kwon OC; Lee JS; Kim YG; Lee CK; Yoo B; Hong S
    Clin Rheumatol; 2018 Dec; 37(12):3215-3220. PubMed ID: 29383453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of ceftobiprole medocaril against Enterococcus faecalis in a mouse peritonitis model.
    Arias CA; Singh KV; Panesso D; Murray BE
    J Antimicrob Chemother; 2007 Sep; 60(3):594-8. PubMed ID: 17606481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.